Published in Cancer Epidemiol Biomarkers Prev on December 02, 2013
Cancer Care Access and Outcomes for American Indian Populations in the United States: Challenges and Models for Progress. Semin Radiat Oncol (2016) 0.75
Cancer Stage in American Indians and Alaska Natives Enrolled in Medicaid. Am J Prev Med (2016) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005). Cancer Epidemiol Biomarkers Prev (2009) 2.46
Health reform and Healthy People initiative. Am J Public Health (2011) 1.13
Introduction to the supplement on cancer in the American Indian and Alaska Native populations in the United States. Cancer (2008) 1.11
Development and use of the North American Association of Central Cancer Registries standards for cancer registries. Top Health Inf Manage (1997) 0.86
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst (2010) 4.04
Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol (2012) 2.72
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer (2006) 2.42
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst (2014) 2.30
Health care costs among renal cancer patients using pazopanib and sunitinib. J Manag Care Spec Pharm (2015) 2.15
Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw (2012) 2.13
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.11
Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. J Comp Eff Res (2012) 1.91
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med (2014) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol (2002) 1.84
Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med (2003) 1.79
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol (2009) 1.76
Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology (2004) 1.71
Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Med Decis Making (2013) 1.70
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med (2007) 1.68
Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm (2015) 1.67
The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics (2009) 1.56
Using an ecological ethics framework to make decisions about the relocation of wildlife. Sci Eng Ethics (2008) 1.48
Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care (2007) 1.38
Breast cancer in limited-resource countries: health care systems and public policy. Breast J (2006) 1.35
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med (2012) 1.32
Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization. Med Care (2005) 1.31
Economic burden for informal caregivers of lung and colorectal cancer patients. Oncologist (2010) 1.30
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion (2004) 1.29
Gene expression profiling and breast cancer care: what are the potential benefits and policy implications? Genet Med (2005) 1.27
Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care (2010) 1.24
End-of-life care in the intensive care unit: can we simultaneously increase quality and reduce costs? Am J Respir Crit Care Med (2012) 1.20
Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States. Liver Transpl (2012) 1.19
Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol (2009) 1.17
Measuring costs: administrative claims data, clinical trials, and beyond. Med Care (2002) 1.16
Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer. Am J Med (2005) 1.16
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer. Value Health (2008) 1.16
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD (2007) 1.12
Economic analyses of human genetics services: a systematic review. Genet Med (2005) 1.10
Within the hidden epidemic: sexually transmitted diseases and HIV/AIDS among American Indians and Alaska Natives. Sex Transm Dis (2007) 1.10
Does adherence make a difference? Results from a community-based aquatic exercise program. Nurs Res (2002) 1.10
New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder. J Am Geriatr Soc (2012) 1.08
Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC). Lung Cancer (2008) 1.06
Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology (2014) 1.05
Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program. Clin Trials (2012) 1.03
Health technology assessment in health-care decisions in the United States. Value Health (2009) 1.03
A multifaceted intervention in support of diabetes treatment guidelines: a cont trial. Diabetes Res Clin Pract (2002) 1.02
Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer. J Oncol Pract (2013) 1.01
Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD (2008) 1.00
Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. J Natl Cancer Inst (2013) 0.98
Stakeholder perspectives on a risk-benefit framework for genetic testing. Public Health Genomics (2010) 0.98
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int (2011) 0.98
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007). Contemp Clin Trials (2012) 0.97
Improving early cycle economic evaluation of diagnostic technologies. Expert Rev Pharmacoecon Outcomes Res (2014) 0.96
An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol (2009) 0.95
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making (2005) 0.94
Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state. J Oncol Pract (2013) 0.93
Economic analyses and clinical practice guidelines: why not a match made in heaven? J Gen Intern Med (2002) 0.93
Is distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer? J Rural Health (2011) 0.93
Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis. Cancer Causes Control (2010) 0.92
Clinical use of medical devices in the 'Bermuda Triangle'. Health Aff (Millwood) (2004) 0.92
Pharmacoeconomic evaluations in the treatment of non-small cell lung cancer. Drugs (2008) 0.92
Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. J Clin Oncol (2005) 0.92
Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program. Cancer (2013) 0.92
Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs. Am J Manag Care (2004) 0.91
Home telemedicine for paediatric palliative care. Stud Health Technol Inform (2010) 0.90
Preference values associated with stage III colon cancer and adjuvant chemotherapy. Qual Life Res (2010) 0.89
Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy. Epilepsia (2011) 0.88
Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer. Gastroenterology (2003) 0.87
Systematic review of comparative effectiveness data for oncology orphan drugs. Am J Manag Care (2012) 0.86
Lifetime cancer-attributable cost of care for long term survivors of colorectal cancer. Am J Gastroenterol (2002) 0.86
Completion of radiotherapy for local and regional head and neck cancer in medicare. Arch Otolaryngol Head Neck Surg (2009) 0.86
The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma. Cancer (2005) 0.86
Lung cancer histology, stage, treatment, and survival in American Indians and Alaska Natives and whites. Cancer (2010) 0.85
Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 0.85
Association of acculturation with cesarean section among Latinas. Matern Child Health J (2005) 0.85
Facilitating comparative effectiveness research in cancer genomics: evaluating stakeholder perceptions of the engagement process. J Comp Eff Res (2012) 0.84
Cardiac procedures among American Indians and Alaska Natives compared to non-Hispanic whites hospitalized with ischemic heart disease in California. J Gen Intern Med (2010) 0.84
The feasibility of a community-based mobile telehealth screening service for Aboriginal and Torres Strait Islander children in Australia. Telemed J E Health (2010) 0.83
Evidence-based management: using serial firm trials to improve diabetes care quality. Jt Comm J Qual Improv (2002) 0.83
Screening for the Lynch syndrome. N Engl J Med (2005) 0.83
Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. Am J Clin Oncol (2010) 0.82
Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases. Appl Health Econ Health Policy (2014) 0.82
Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer. Oncologist (2014) 0.82
Promoting quality and evidence-based care in early-stage breast cancer follow-up. J Natl Cancer Inst (2014) 0.82
Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer (2010) 0.82
The outcomes of the cancer outcomes research symposium: a commentary. Med Care (2002) 0.81
A pilot study of the effectiveness of home teleconsultations in paediatric palliative care. J Telemed Telecare (2012) 0.81
Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population. Int J Gen Med (2011) 0.81
A guideline for the use of pharmacoeconomic models of diabetes treatment in the US managed-care environment. Pharmacoeconomics (2002) 0.81
Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs. Oncologist (2013) 0.80
Health care use and primary prophylaxis with colony-stimulating factors. Value Health (2011) 0.80
How should we value lives lost to cancer? J Natl Cancer Inst (2008) 0.79
Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients. Patient (2008) 0.79
Do better-rated navigators improve patient satisfaction with cancer-related care? J Cancer Educ (2013) 0.79
Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis. J Cancer Res Clin Oncol (2009) 0.79